The global burden of lung cancer: current status and future trends

A Leiter, RR Veluswamy, JP Wisnivesky - Nature reviews Clinical …, 2023 - nature.com
Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer
incidence and mortality rates differ substantially across the world, reflecting varying patterns …

Lung cancer screening

SJ Adams, E Stone, DR Baldwin, R Vliegenthart, P Lee… - The Lancet, 2023 - thelancet.com
Randomised controlled trials, including the National Lung Screening Trial (NLST) and the
NELSON trial, have shown reduced mortality with lung cancer screening with low-dose CT …

Screening for lung cancer: 2023 guideline update from the American Cancer Society

AMD Wolf, KC Oeffinger, TYC Shih… - CA: A Cancer …, 2024 - Wiley Online Library
Lung cancer is the leading cause of mortality and person‐years of life lost from cancer
among US men and women. Early detection has been shown to be associated with reduced …

Screening for lung cancer with low-dose computed tomography: updated evidence report and systematic review for the US Preventive Services Task Force

DE Jonas, DS Reuland, SM Reddy, M Nagle, SD Clark… - Jama, 2021 - jamanetwork.com
Importance Lung cancer is the leading cause of cancer-related death in the US. Objective To
review the evidence on screening for lung cancer with low-dose computed tomography …

Lung cancer LDCT screening and mortality reduction—evidence, pitfalls and future perspectives

M Oudkerk, SY Liu, MA Heuvelmans… - Nature reviews Clinical …, 2021 - nature.com
In the past decade, the introduction of molecularly targeted agents and immune-checkpoint
inhibitors has led to improved survival outcomes for patients with advanced-stage lung …

[PDF][PDF] 中国肺癌筛查与早诊早治指南(2021, 北京)

赫捷, 李霓, 陈万青, 吴宁, 沈洪兵, 江宇, 李江… - 中华肿瘤 …, 2021 - suanfayisheng.com
肺癌是中国发病率和死亡率最高的恶性肿瘤. 筛查与早诊早治是降低人群肺癌死亡率的有效措施
. 制定符合中国国情的肺癌筛查与早诊早治指南, 将极大推进中国肺癌筛查的同质性和优质性 …

[HTML][HTML] Global epidemiology of lung cancer

JA Barta, CA Powell, JP Wisnivesky - Annals of global health, 2019 - ncbi.nlm.nih.gov
While lung cancer has been the leading cause of cancer-related deaths for many years in
the United States, incidence and mortality statistics–among other measures–vary widely …

One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study

N Li, F Tan, W Chen, M Dai, F Wang, S Shen… - The Lancet …, 2022 - thelancet.com
Background Lung cancer is the leading cause of cancer death worldwide. Data on the
effectiveness of one-off low-dose CT (LDCT) in reducing lung cancer mortality and all-cause …

[HTML][HTML] Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy

U Pastorino, M Silva, S Sestini, F Sabia, M Boeri… - Annals of …, 2019 - Elsevier
ABSTRACT Background The National Lung Screening Trial showed that lung cancer (LC)
screening by three annual rounds of low-dose computed tomography (LDCT) reduces LC …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

CF Vogelmeier, GJ Criner, FJ Martinez… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …